15 Stocks Set to Explode in 2026

Page 5 of 13

9. Beam Therapeutics Inc. (NASDAQ:BEAM)

Number of Hedge Fund Holders: 31

Upside Potential: 105.67%

With significant upside potential and hedge fund interest, Beam Therapeutics Inc. (NASDAQ:BEAM) secured a spot on our list of the 15 stocks set to explode in 2026.

On November 5, 2025, Clear Street increased its price target on Beam Therapeutics Inc. (NASDAQ:BEAM) from $34 to $37, while maintaining a “Buy” rating.

The revised target reflected the company’s robust performance in the third quarter of 2025. The investment firm pointed toward the first patient dosing in Beam Therapeutics Inc. (NASDAQ:BEAM)’s BEAM-103 healthy volunteer study, which is a key achievement in its ESCAPE platform. Furthermore, Clear Street highlighted the company’s upcoming BEAM-302 interim update in early 2026 as a key catalyst. The firm also praised the company’s increased strength in its balance sheet, evident from its 17% stake in Orbital Therapeutics, which is valued at roughly $255 million following its $1.5 billion buyout by Bristol Myers Squibb.

Meanwhile, on the previous day, Beam Therapeutics Inc. (NASDAQ:BEAM) reported advancement across its hematology and genetic disease franchises. The company’s management emphasized continued dosing in the BEAM-302 trial for alpha-1 antitrypsin deficiency, alongside new data from BEAM-101 expected at the December ASH meeting.

The investor confidence in Beam Therapeutics Inc. (NASDAQ:BEAM) is also evident from Cathie Wood’s ARK purchase of 291,001 shares, worth $7.06 million, on November 4, 2025.

With its proprietary base editing platform, Beam Therapeutics Inc. (NASDAQ: BEAM) develops precision genetic medicines that enable targeted single-base changes for treating serious diseases.

Page 5 of 13